SEC Form 3/A · accession 0001493152-18-009493
Biostar Angel Stem Cell Corp
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 3/A). It replaces an earlier filing for the same period.
Reporting owner
Jeong chan Ra
10% Owner
Period of report
Jan 16, 2018
Accepted (ET)
Jun 29, 2018 · 9:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001709474
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | holding | — | — | — | 4,500,000 | D | ||
| Preferred Stock, par value $0.0001 per share | holding | — | — | — | 10,000,000 | D | ||
| Common Stock, par value $0.0001 per shareF1 | holding | — | — | — | 2,000,000 | I | By R-Bio Co. Ltd. | |
| Common Stock, par value $0.0001 per shareF2 | holding | — | — | — | 2,500,000 | I | By Nature Cell Co. Ltd. |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Mr. Ra is the controlling shareholder and Chief Executive Officer of R-Bio Co. Ltd. and has an indirect pecuniary interest in the securities. Mr. Ra disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
- F2Mr. Ra is the controlling shareholder and Chief Executive Officer of Nature Cell Co. Ltd. and has an indirect pecuniary interest in the securities. Mr. Ra disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.